More Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A news Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class ASZSE: 002773 Chengdu Kanghong Pharmaceutical Q1 Net Profit Down 23.1% Y/Y Apr 22, 2026 at 12:41 PM UTC · Issued by Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A As issuedPlain English Chengdu Kanghong Pharmaceutical Group Co Ltd SZSE:002773:Q1 NET PROFIT DOWN 23.1% Y/Y2025 NET PROFIT DOWN 2.4% Earlier from Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class AChengdu Kanghong: US FDA Approves KHN921 Clinical Trial For Hypertrophic Cardiomyopathy TreatmentApr 19All Chengdu Kanghong Pharmaceutical Group Co., Ltd. Class A news releases↗
